TO
Tozlu, Ozlem Ozdemir
20 papers · 205 citations · 2021–2026
Publications
20
Citations
205
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Combined In Vitro and In Silico Evidence for Neuroprotection by Selected Sodium and Potassium Salts in an H<sub>2</sub>O<sub>2</sub>-Induced SH-SY5Y Neurodegeneration Model
|
2026 | Article | 0 |
|
Anti-Tumoral Effects of Pomegranate Fruit Membranes Across Different Phenotypes
|
2025 | Article | 0 |
|
Colemanite and biological disruptions: Behavioral, neurological, and physiological findings
|
2025 | Article | 2 |
|
Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats
|
2025 | Article | 4 |
|
Boric acid impedes glioblastoma growth in a rat model: insights from multi-approach analysis
|
2025 | Article | 2 |
|
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning ( vol 83 , 104214 , 2022)
|
2024 | Correction | 0 |
|
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)
|
2024 | Retraction | 0 |
|
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
|
2024 | Article | 7 |
|
In Vitro Cytotoxic, Genotoxic, Embryotoxic and Oxidative Damage Potentials by Empagliflozin
|
2024 | Article | 0 |
|
Boric Acid and Borax Protect Human Lymphocytes from Oxidative Stress and Genotoxicity Induced by 3-Monochloropropane-1,2-diol
|
2024 | Article | 6 |
|
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
|
2023 | Article | 6 |
|
Low vitamin D and high cholesterol facilitate oral carcinogenesis in 4NQO-induced rat models via regulating glycolysis
|
2023 | Article | 11 |
|
Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
|
2023 | Article | 11 |
|
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
|
2023 | Article | 60 |
|
Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives
|
2022 | Article | 2 |
|
<i>In Vitro</i> and <i>In Vivo</i> Neuroprotective Effects of Sarcosine
|
2022 | Article | 21 |
|
Discovery of therapeutic agents targeting <i>PKLR </i>for <i>NAFLD </i>using drug repositioning
|
2022 | Article | 22 |
|
Boron Compounds Exhibit Protective Effects against Aluminum-Induced Neurotoxicity and Genotoxicity: In Vitro and In Vivo Study
|
2022 | Article | 30 |
|
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity
|
2022 | Article | 12 |
|
Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies
|
2021 | Article | 9 |